Do standard drug doses work for the sickest patients? study investigates.
NCT ID NCT02164890
Summary
This study aimed to understand how the antifungal drug micafungin behaves in the bodies of critically ill patients in intensive care. Researchers measured drug levels in 60 patients with serious fungal infections to see if the standard dose is sufficient or if some patients might need a different amount. The goal was to gather information to help doctors personalize treatment for better outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE CANDIDIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Montpellier
Montpellier, 34295, France
Conditions
Explore the condition pages connected to this study.